senate
Posted on July 6, 2012 in Long-Term Care, Home Health & Hospice
Written by: Bufford, David W.
In an on-going push to regulate the use of antipsychotic medications in nursing facilities, another piece of legislation has failed to pass Congress. The Senate did not pass a proposed regulation that would have standardized protocols for obtaining informed consent before administering antipsychotics for off-label use. READ MORE
Posted on May 31, 2012 in Long-Term Care, Home Health & Hospice
Written by: Bufford, David W.
On the heels of last week’s failure for the antipsychotic measures to pass the Senate, the Centers for Medicare & Medicaid Services (CMS) has just announced an initiative to reduce antipsychotic use in nursing facilities. Yesterday, CMS officials announced a multi-year initiative to improve dementia care for residents of nursing homes by reducing the inappropriate... READ MORE
Posted on May 29, 2012 in Long-Term Care, Home Health & Hospice
Written by: Bufford, David W.
Last Thursday, a proposed regulation aimed at curbing the high levels of “off-label” uses for antipsychotic medications failed to pass the Senate. This proposed legislation relates back to a report last November by Daniel R. Levinson, the U.S. Inspector General, that exposed the high levels of antipsychotic medications administered to nursing facility residents. That report stated a... READ MORE
